LambdaVision, a U.S.-based biotechnology company developing artificial retinas, said on Wednesday it had raised $7 million in a seed funding round to support its manufacturing efforts in low-Earth orbit (LEO) and extend operations through 2027.<\/p>\n
The round was led by Seven Seven Six and Aurelia Foundry Fund, with additional participation from Seraphim Space. The company said the funding will accelerate work on its protein-based artificial retina and help move toward human clinical trials.<\/p>\n
\u201cThis seed round funding will help bring us closer to clinical trials, and continue to pioneer scalable production of our artificial retina, including manufacturing techniques implemented in low-Earth orbit,\u201d said LambdaVision Chief Executive Nicole Wagner.<\/p>\n
Founded with the goal of restoring vision to patients suffering from degenerative retinal diseases, LambdaVision believes microgravity conditions in space offer a more efficient environment for fabricating its multilayered protein films. Such films form the foundation of its artificial retina technology, designed to address disorders that impact millions of people worldwide.<\/p>\n
The company has flown nine missions to the International Space Station (ISS) to refine its process, including the creation of a 200-layer protein thin film that serves as a precursor to its final product. In September, LambdaVision received a NASA Phase 2 In Space Production Applications award to advance its in-orbit manufacturing in partnership with research firm Space Tango.<\/p>\n
LambdaVision said the $7 million announced this week represents new capital following the first closing of its seed round in May 2024. The company plans to continue fundraising as it prepares for a future Series A round to further scale production and development.<\/p><\/p>\n","protected":false},"excerpt":{"rendered":"
LambdaVision, a U.S.-based biotechnology company developing artificial retinas, said on Wednesday it had raised $7 million in a seed funding round to support its manufacturing efforts in low-Earth orbit (LEO) and extend operations through 2027. The round was led by Seven Seven Six and Aurelia Foundry Fund, with additional participation from Seraphim Space. The company […]<\/p>\n","protected":false},"author":1,"featured_media":20451,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[259,6853,609],"class_list":["post-20448","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-funding","tag-lambdavision","tag-seraphim-space"],"acf":[],"_links":{"self":[{"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/posts\/20448"}],"collection":[{"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/comments?post=20448"}],"version-history":[{"count":0,"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/posts\/20448\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/media\/20451"}],"wp:attachment":[{"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/media?parent=20448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/categories?post=20448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/starpath.global\/blog\/wp-json\/wp\/v2\/tags?post=20448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}